BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6499878)

  • 21. 131I ovarian uptake in a whole-body scan for thyroid carcinoma.
    Zwas ST; Heyman Z; Lieberman LM
    Semin Nucl Med; 1989 Oct; 19(4):340-2. PubMed ID: 2799406
    [No Abstract]   [Full Text] [Related]  

  • 22. Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature.
    Campennì A; Giovinazzo S; Tuccari G; Fogliani S; Ruggeri RM; Baldari S
    Arch Endocrinol Metab; 2015 Aug; 59(4):351-4. PubMed ID: 26331324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal thoracic uptake mimicking lung metastasis on 131I post-therapy whole-body scan in patients with thyroid carcinoma.
    Jia C; Moadel R; Freeman LM
    Clin Nucl Med; 2014 Apr; 39(4):360-2. PubMed ID: 24598344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
    Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma.
    Lee HJ; Rha SY; Jo YS; Kim SM; Ku BJ; Shong M; Kim YK; Ro HK
    Am J Clin Oncol; 2007 Feb; 30(1):63-8. PubMed ID: 17278897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low levels of serum thyroglobulin after withdrawal of thyroid suppression therapy in the follow up of differentiated thyroid carcinoma.
    Brendel AJ; Lambert B; Guyot M; Jeandot R; Dubourg H; Roger P; Wynchauk S; Manciet G; Lefort G
    Eur J Nucl Med; 1990; 16(1):35-8. PubMed ID: 2307172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unusual ¹³¹I uptake in a benign mucinous cystadenoma of the ovary in a patient with papillary thyroid cancer.
    Qiu ZL; Xu YH; Song HJ; Luo QY
    Clin Nucl Med; 2010 Dec; 35(12):965-6. PubMed ID: 21206234
    [No Abstract]   [Full Text] [Related]  

  • 28. Radioiodine uptake in an ovarian mature teratoma detected with SPECT/CT.
    Yazici B; Oral A; Omur O; Yazici A
    Clin Nucl Med; 2015 Feb; 40(2):e157-60. PubMed ID: 25140551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning.
    Dam HQ; Kim SM; Lin HC; Intenzo CM
    Radiology; 2004 Aug; 232(2):527-33. PubMed ID: 15286323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
    Koh JM; Kim ES; Ryu JS; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
    Yamazaki CA; Padovani RP; Biscolla RP; Ikejiri ES; Marchetti RR; Castiglioni ML; Matsumura LK; Maciel RM; Furlanetto RP
    Thyroid; 2012 Oct; 22(10):1002-6. PubMed ID: 22953991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of mediastinal uptake of 131I with regard to surgery in patients with differentiated thyroid carcinoma.
    Haveman JW; Phan HT; Links TP; Jager PL; Plukker JT
    Cancer; 2005 Jan; 103(1):59-67. PubMed ID: 15565567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian dermoid cyst serendipitously detected by pelvic radioiodine-(131)I uptake and by diffusion weighted MRI in a post-thyroidectomy case of papillary thyroid carcinoma.
    Basu S; Mahajan A
    Hell J Nucl Med; 2013; 16(1):62-3. PubMed ID: 23529395
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of thyroid carcinoma with radioactive 131I.
    Paryani SB; Chobe RJ; Scott W; Wells J; Johnson D; Kuruvilla A; Schoeppel S; Deshmukh A; Miller R; Dajani L; Montgomery CT; Puestow E; Purcell J; Roura M; Sutton D; Mallett R; Peer J
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):83-6. PubMed ID: 8823262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follicular thyroid carcinoma and mediastinal goiter in a case of situs inversus viscerum.
    Panza N; Mansi L; Pacilio C; Lombardi G
    Q J Nucl Med; 1995 Jun; 39(2):116-8. PubMed ID: 8574804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Struma ovarii maligna.
    Matysiak-Grzes M; Fischbach J; Gut P; Klimowicz A; Gryczynska M; Wasko R; Ruchala M
    Neuro Endocrinol Lett; 2013; 34(2):97-101. PubMed ID: 23645304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pitfall of I-131 whole body scan: a mucinous adenocarcinoma of the ovary.
    Sellem A; Msakni I; Elajmi W; Hammami H
    Pan Afr Med J; 2020; 36():72. PubMed ID: 32774631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma.
    Travagli JP; Cailleux AF; Ricard M; Baudin E; Caillou B; Parmentier C; Schlumberger M
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2675-80. PubMed ID: 9709930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False-positive 131I whole-body scan in well-differentiated thyroid cancer patient with respiratory bronchiolitis.
    Thientunyakit T
    Clin Nucl Med; 2013 Sep; 38(9):730-4. PubMed ID: 23510883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of hepatic visualization on iodine-131 whole-body scan in patients with thyroid carcinoma.
    Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC; Cho BY; Koh CS
    J Nucl Med; 1997 Aug; 38(8):1191-5. PubMed ID: 9255147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.